615 research outputs found
Projected Linear Response Theory for Charge-Exchange Excitations and Double Beta Decay
The projected random phase approximation (PRPA) for charge-exchange
excitations is derived from the time-dependent variational principle. Explicit
results for the unperturbed energies (including the self-energy corrections),
the PRPA matrices, and the transition matrix elements are presented. The effect
of the projection procedure on the two-neutrino decay in
is briefly discussed.Comment: 12 pages text (LaTex) and 1 figure upon request, to be published in
Phys. Lett.
Nuclear moments for the neutrinoless double beta decay II
The recently developed formalism for the evaluation of nuclear form factors
in neutrinoless double beta decay is applied to , ,
, , and nuclei. Explicit analytical
expressions that follows from this theoretical development, in the single mode
model for the decay of , have been worked out. They are useful both
for testing the full numerical calculations, and for analytically checking the
consistency with other formalisms. Large configuration space calculations are
compared with previous studies, where alternative formulations were used. Yet,
besides using the G-matrix as residual interaction, we here use a simple
-force. Attention is paid to the connected effects of the short range
nuclear correlations and the finite nucleon size. Constraints on lepton number
violating terms in the weak Hamiltonian (effective neutrino Majorana mass and
effective right-handed current coupling strengths) are deduced.Comment: 18 pages, latex, minor changes, to appear in Nucl. Phys.
Weak Magnetism in Two Neutrino Double Beta Decay
We have extended the formalism for the two-neutrino double beta decay by
including the weak-magnetism term, as well as other second-forbidden
corrections. The weak magnetism diminishes the calculated half-lives in , independently of the nuclear structure. Numerical computations were
performed within the pn-QRPA, for , , ,
and nuclei. No one of the second-forbidden corrections modifies
significantly the spectrum shapes. The total reduction in the calculated half
lives varies from 6% up to 32%, and strongly depend on the nuclear interaction
in the particle-particle channel. We conclude that the higher order
effects in the weak Hamiltonian would hardly be observed in the two-neutrino
double beta experiments.Comment: 8 pages, latex, 1ps figure, to appear in Phys. Lett.
Exact evaluation of the nuclear form factor for new kinds of majoron emission in neutrinoless double beta decay
We have developed a formalism, based on the Fourier-Bessel expansion, that
facilitates the evaluation of matrix elements involving nucleon recoil
operators, such as appear in serveral exotic forms of neutrinoless double beta
decay (). The method is illustrated by applying it to the
``charged'' majoron model, which is one of the few that can hope to produce an
observable effect. From our numerical computations within the QRPA performed
for , , , and nuclei, we
test the validity of approximations made in earlier work to simplify the new
matrix elements, showing that they are accurate to within 15%. Our new method
is also suitable for computing other previously unevaluated
nuclear matrix elements.Comment: 11pp., latex, fixed minor typographical error
Competition between standard and exotic double beta decays
We discuss the contributions of higher order terms in weak Hamiltonian to the
standard two-neutrino double beta decay. The formalism for the unique first
forbidden transitions has been developed, and it is shown that they can alter
the two-electron energy spectrum. Yet, their effect is too small to screen the
detection of exotic neutrinoless double beta decays, which are candidates for
testing the physics beyond the standard model.Comment: 9 pages, latex, 1ps figures, minor changes, to appear in Phys. Lett.
Two neutrino double beta decay within the -approximation
We examine the contributions of odd-parity nuclear operators to the
two-neutrino double beta decay amplitude, which come from
the -wave Coulomb corrections to the electron wave functions and the recoil
corrections to the nuclear currents. Although they are formally of higher order
in or of the nucleon than the usual Fermi and Gamow-Teller
matrix elements, explicit calculations performed within the QRPA show that they
are significant when confronted with the experimental data.Comment: 9 pages, latex, no figure
Application of CAR-T cells in cancer gene therapy
Genska terapija predstavlja obeÄavajuÄi terapijski alat za lijeÄenje onih bolesti koje se konvencionalnim metodama lijeÄenja nisu uspjeÅ”no uspijele eliminirati. OtkriÄa u podruÄju humane genomike su, uz znaÄajan tehnoloÅ”ki napredak, doprinijela njezinoj primjeni u lijeÄenju Å”irokog spektra bolesti. UnatoÄ mnogobrojnim provedenim istraživanjima i razvoju raznih potencijalnih terapija, rak je i dalje vodeÄi uzrok smrti u svijetu. Stoga je veliki broj kliniÄkih istraživanja, koja primjenjuju strategije genske terepije, usmjereno njegovoj redukciji i eliminaciji. Tijekom niza godina predložene su brojne strategije genske terapije tumora od kojih je veÄina bila kliniÄki neuspjeÅ”na. MeÄutim, tijekom posljednjih nekoliko godina, novi oblik imunoterapije zadobiva veliku pozornost u istraživanju uslijed visoke terapeutske uÄinkovitosti. RijeÄ je o terapiji CAR-T koja objedinjuje strategije genske terapije, staniÄne terapije i imunoterapije. Ovaj rad donosi kratki pregled nekih od glavnih strategija genske terapije u lijeÄenja tumora s posebnim osvrtom na adaptivnu staniÄnu terapiju CAR-T. TakoÄer, u radu su izloženi nedostaci i Å”tetne nuspojave, kao i strategije razvoja sigurnije i uÄinkovitije terapije.Gene therapy is a promising therapeutic tool for the treatment of diseases not eliminated by conventional treatment methods. Discoveries in the field of human genomics have, along with the significant technological advances, contributed to its application in the treatment of a wide range of diseases. Despite numerous studies and development of variety potential therapies, cancer remains the leading cause of death in the world. Therefore, a large number of clinical studies, that apply gene therapy strategies, are directed towards its reduction and elimination. Over the course of many years, a number of cancer gene therapy strategies have been proposed, most of which were clinically unsuccessful. However, over the last few years, a new form of immunotherapy has gained great attention in research due to high therapeutic efficacy. Therapy in question is CAR-T therapy that combines gene therapy, cell therapy and immunotherapy strategies. This paper provides a brief overview of some of the major gene therapy strategies for cancer treatment, with a special focus on adaptive CAR-T therapy. Also, the paper presents disadvantages and adverse side effects, as well as strategies for developing safer and more effective therapy
- ā¦